Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

被引：0
|
作者：
Tereza Lanitis
Irina Proskorovsky
Apoorva Ambavane
Matthias Hunger
Ying Zheng
Murtuza Bharmal
Hemant Phatak
机构：
[1] Evidera,
[2] Evidera,undefined
[3] Mapi,undefined
[4] an ICON plc company,undefined
[5] EMD Serono Inc.,undefined
[6] Merck KGaA,undefined
来源：
Advances in Therapy | 2019年 / 36卷
关键词：
Avelumab; Extrapolation; Immuno-oncology; Landmark analyses; Merkel cell carcinoma; Overall survival; Post-progression survival; Standard parametric analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2327 / 2341
页数：14
相关论文
共 50 条
  • [1] Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab
    Lanitis, Tereza
    Proskorovsky, Irina
    Ambavane, Apoorva
    Hunger, Matthias
    Zheng, Ying
    Bharmal, Murtuza
    Phatak, Hemant
    ADVANCES IN THERAPY, 2019, 36 (09) : 2327 - 2341
  • [2] Lethal thrombocytopenia in a patient treated with avelumab for metastatic Merkel cell carcinoma
    Kratzsch, Dorothea
    Simon, Jan-Christoph
    Poenitzsch, Iris
    Ziemer, Mirjana
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 (01): : 73 - 75
  • [3] BUDGET IMPACT ANALYSIS OF AVELUMAB IN PATIENTS WITH METASTATIC MERKEL CELL CARCINOMA IN THE US
    Bharmal, M.
    D'Angelo, S. P.
    Phatak, H.
    VALUE IN HEALTH, 2017, 20 (09) : A424 - A424
  • [4] Avelumab for the treatment of metastatic Merkel cell carcinoma
    Cordes, L. M.
    Gulley, J. L.
    DRUGS OF TODAY, 2017, 53 (07) : 377 - 383
  • [5] Avelumab: A Review in Metastatic Merkel Cell Carcinoma
    Shirley, Matt
    TARGETED ONCOLOGY, 2018, 13 (03) : 409 - 416
  • [6] Avelumab: A Review in Metastatic Merkel Cell Carcinoma
    Matt Shirley
    Targeted Oncology, 2018, 13 : 409 - 416
  • [7] Immunogenicity of avelumab in patients with metastatic Merkel cell carcinoma or advanced urothelial carcinoma
    Hu, Ping
    Dai, Haiqing Isaac
    Bourdage, James
    Zhou, Dongli
    Trang, Ky
    Kowalski, Karey
    Bello, Carlo
    Hibma, Jennifer
    Khandelwal, Akash
    Cowan, Kyra
    Dong, Jennifer
    Venkatakrishnan, Karthik
    Gao, Wei
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (03):
  • [8] Predicting overall survival in patients (pts) with treatment-naive metastatic Merkel cell carcinoma (mMCC) treated with avelumab.
    Bullement, Ash
    D'Angelo, Sandra P.
    Amin, Amerah
    Stapelkamp, Ceilidh
    Willis, Anna
    Lilley, Cameron
    Hatswell, Anthony
    Bharmal, Murtuza
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Re-induction of avelumab for patients with metastatic merkel cell carcinoma
    Hiroyuki, Goto
    Yuichi, Yoshida
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (02)
  • [10] Exploratory biomarker analysis in avelumab-treated patients with metastatic Merkel cell carcinoma progressed after chemotherapy.
    Shapiro, Irina
    Grote, Hans Juergen
    D'Urso, Vittorio
    von Heydebreck, Anja
    Mahnke, Lisa
    Kaufman, Howard
    Nghiem, Paul
    Cal, Ti
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345